Burning Rock Biotech Ltd Quarterly Cash and Cash Equivalents, at Carrying Value in CNY from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Burning Rock Biotech Ltd quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2018 to Q4 2023.
  • Burning Rock Biotech Ltd Cash and Cash Equivalents, at Carrying Value for the quarter ending December 31, 2023 was ¥615M, a 32.1% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (CNY)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 615M -290M -32.1% Dec 31, 2023 20-F 2024-04-29
Q4 2022 905M -526M -36.7% Dec 31, 2022 20-F 2024-04-29
Q2 2022 1.15B -704M -38% Jun 30, 2022 6-K 2022-11-07
Q4 2021 1.43B -464M -24.5% Dec 31, 2021 20-F 2024-04-29
Q2 2021 1.85B Jun 30, 2021 6-K 2022-11-07
Q4 2020 1.9B +1.8B +1911% Dec 31, 2020 20-F 2023-04-20
Q4 2019 94.2M +894K +0.96% Dec 31, 2019 20-F 2022-04-29
Q4 2018 93.3M Dec 31, 2018 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.